Tlr9 activation increases tap-independent vesicular mhc class i processing in vivo

Scandinavian Journal of Immunology

Volumn 70, Issue 5, 2009, Pages 431-438

  Chen, L ^a   Jondal, M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN S; CPG OLIGODEOXYNUCLEOTIDE; GLYCOPROTEIN P 15095; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; PEPTIDE TRANSPORTER 1; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GOLGI COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, LY; CROSS-PRIMING; CYTOPLASMIC VESICLES; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; PEPTIDE FRAGMENTS; TOLL-LIKE RECEPTOR 9;

EID: 70350510999     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02315.x     Document Type: Article

References (32)

1. Reis E Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 2006 6 : 476 483.
2. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002 23 : 445 449.
3. Heath HR, Carbone FR. Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 2001 19 : 47 64.
4. Rock KL, Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev 2005 207 : 166 183.
5. Kavocsovics-Bankowski M, Rock KL. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995 267 : 243 246.
6. Delamarre L, Holcombe H, Mellman I. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J Exp Med 2003 198 : 111 122.
7. Jiang A, Bloom O, Ono S et al. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 2007 27 : 610 624.
8. Burgdorf S, Schölz C, Kautz A, Tampé R, Kurts C. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol 2008 9 : 558 566.
9. Di Pucchio T, Chatterjee B, Smed-Sörensen A et al. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat Immunol 2008 9 : 551 557.
10. Ackerman AL, Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat Immunol 2004 5 : 678 684.
11. Chen L, Jondal M. Alternative processing for MHC class I presentation by immature and CpG-activated dendritic cells. Eur J Immunol 2004 34 : 952 960.
12. Chen L, Jondal M. Endolysosomal processing of exogenous antigen into major histocompatibility complex class I-binding peptides. Scand J Immunol 2004 59 : 545 552.
13. Chen L, Jondal M. Brefeldin A inhibits vesicular MHC class I processing in resting but not in CpG- and disruption-activated DC. Mol Immunol 2008 46 : 158 165.
14. Lizée G, Basha G, Tiong J et al. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat Immunol 2003 4 : 1065 1073.
15. Shen L, Sigal LJ, Boes M, Rock KL. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 2004 21 : 155 165.
16. Takeshita F, Gursel I, Ishii KJ, Suzuki K, Gursel M, Klinman DM. Signal transduction pathways mediated by the interaction of CpG DNA with toll-like receptor 9. Semin Immunol 2004 16 : 17 22.
17. Maurer T, Heit A, Hochrein H et al. CpG-DNA aided cross-presentation of soluble antigens by dendritic cells. Eur J Immunol 2002 32 : 2356 2364.
18. Shi GP, Villadangos JA, Dranoff G et al. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 1999 10 : 197 206.
19. + T cells. Cell 1992 71 : 1205 1214.
20. Hemmi H, Takeuchi O, Kawai T et al. A toll-like receptor recognizes bacterial DNA. Nature 2000 408 : 740 745.
21. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T-cell receptor antagonist peptides induce positive selection. Cell 1999 76 : 17 27.
22. Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN. Localization, quantitation, and in situ detection of specific peptide - MHC class I complexes using a monoclonal antibody. Immunity 1997 6 : 715 726.
23. De St Groth BF, Smith AL, Koh WP, Girgis L, Cook MC, Bertolino P. Carboxyfluorescein diacetate succinimidyl ester and the virgin lymphocyte: a marriage made in heaven. Immunol Cell Biol 1999 77 : 530 538.
24. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001 106 : 255 258.
25. Tiwari N, Garbi N, Reinheckel T, Moldenhauer G, Hämmerling GJ, Momburg F. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins. J Immunol 2007 178 : 7932 7942.
26. Ahmad-Nejad P, Häcker H, Rutz M, Bauer S, Vabulas RM, Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate toll-like receptors at distinct cellular compartments. Eur J Immunol 2002 32 : 1958 1968.
27. Chen L, Fredholm BB, Jondal M. Adenosine, through the A1 receptor, inhibits vesicular MHC class I cross-presentation by resting DC. Mol Immunol 2008 45 : 2247 2254.
28. Wagner H. The immunogenicity of CpG-antigen conjugates. Adv Drug Deliv Rev 2009 61 : 243 247.
29. Nierkens S, den Brok MH, Sutmuller RP et al. In vivo colocalization of antigen and CpG within dendritic cells is associated with the efficacy of cancer immunotherapy. Cancer Res 2008 68 : 5390 5396.
30. Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 2006 5 : 471 484.
31. Villadangos JA, Young L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 2008 29 : 352 361.
32. Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with toll-like receptor agonists and antagonists. Nat Med 2007 13 : 552 559.